Replies to post #176121 on Biotech Values

[read_this_n0w]

ARIA "Rumours from across the Pond now suggest that Jazz Pharmaceuticals, a dynamic pharmaceutical biopharma company, with a market capitalisation of $8billion, is willing to pay $20-plus a share to get its hands on Ariad, which was trading at $7.65 a share early yesterday and has jumped 18 per cent since January on bid speculation.
"

http://www.dailymail.co.uk/money/markets/article-2591126/MARKET-REPORT-Drug-giants-fail-swallow-Ariad-Pharmaceuticals.html

[biomaven0]

>>Suing to stop a merger is a losing game

But not for the lawyers involved ...

I wish some court would have the guts to refuse to approve a settlement that provides lawyers' fees but no appreciable benefits to the class.

Peter